MyAverix Finance
F · Healthcare
ASPEN PHAR.UN.ADR /1 O.N. (LDZU)
Drug Manufacturers - Specialty & Generic
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-29, reported market cap is $2.95B, P/E ratio is 18.00, net margin is -4.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for LDZU
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) — FAQ
What is ASPEN PHAR.UN.ADR /1 O.N.'s market cap?
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) has a reported market cap of $2.95B (data as of 2026-03-29).
What is LDZU's P/E ratio?
The price-to-earnings (P/E) ratio for ASPEN PHAR.UN.ADR /1 O.N. (LDZU) is 18.00 (data as of 2026-03-29).
Does ASPEN PHAR.UN.ADR /1 O.N. pay a dividend?
Dividend yield is not available in the current snapshot for ASPEN PHAR.UN.ADR /1 O.N. (LDZU). Check the MyAverix Finance app for the latest dividend data.
What sector is ASPEN PHAR.UN.ADR /1 O.N. in?
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is LDZU listed on?
LDZU is listed on F.
What is ASPEN PHAR.UN.ADR /1 O.N.'s net margin?
ASPEN PHAR.UN.ADR /1 O.N. (LDZU) reports a net margin of -4.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.